Episodes
-
Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer
August 16th, 2024 | Season 1 | 54 mins 17 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on antibody-drug conjugate-mediated therapies for HR-positive breast cancer and TNBC, with Dr Sara Hurvitz, moderated by Dr Neil Love. Produced by Research To Practice.
-
Novel Agents and Strategies in Lung Cancer
August 13th, 2024 | Season 1 | 1 hr 1 min
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on treatments for lung cancer, with Drs Melissa Johnson, Ticiana Leal and Manish Patel, moderated by Dr Neil Love. Produced by Research To Practice.
-
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma
August 9th, 2024 | Season 1 | 1 hr 2 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion of the most relevant new data sets and advances in multiple myeloma with Drs Jesús G Berdeja and Thomas Martin, moderated by Dr Neil Love. Produced by Research To Practice.
-
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Melanoma and Nonmelanoma Skin Cancers
August 8th, 2024 | Season 1 | 59 mins 35 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on important clinical findings over the past year for patients with skin cancers with Dr Evan J Lipson, moderated by Dr Neil Love. Produced by Research To Practice.
-
Individualizing the Selection of First-Line Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer
August 6th, 2024 | Season 1 | 1 hr 14 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on optimal therapies for patients with HR-positive metastatic breast cancer, with Dr Joyce O’Shaughnessy, moderated by Dr Neil Love. Produced by Research To Practice.
-
An interview with Matthew R Smith, MD, PhD — Management of Prostate Cancer
August 2nd, 2024 | Season 1 | 53 mins 35 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recently presented findings from ASCO 2024 on therapies for prostate cancer, with Dr Matthew R Smith, moderated by Dr Neil Love. Produced by Research To Practice.
-
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer
July 30th, 2024 | Season 1 | 1 hr 53 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on select data sets from 2023 on the management of NSCLC without actionable mutations with Dr Matthew Gubens, moderated by Dr Neil Love. Produced by Research To Practice.
-
Optimizing the Identification of HER2-Low Breast Cancer
July 30th, 2024 | Season 1 | 23 mins 48 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on HER2-low breast cancer with Dr Kimberly H Allison, moderated by Dr Neil Love. Produced by Research To Practice.
-
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic Oncology
July 26th, 2024 | Season 1 | 59 mins 17 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on select data sets from 2023 on the management of gynecologic cancers with Dr Dana M Chase, moderated by Dr Neil Love. Produced by Research To Practice.
-
An interview with Jonathan W Goldman, MD — Management of Non-Small Cell Lung Cancer with an EGFR Mutation
July 24th, 2024 | Season 1 | 47 mins 34 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on findings presented at ASCO 2024 on therapies for NSCLC with an EGFR mutation with Dr Jonathan Goldman, moderated by Dr Neil Love. Produced by Research To Practice.
-
Investigator Perspectives on Available Research and Challenging Questions in Melanoma and Nonmelanoma Skin Cancers: A Post-ASCO 2024 Annual Review
July 19th, 2024 | Season 1 | 1 hr 6 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on results presented at ASCO 2024 on therapies for skin cancers, with Drs Nikhil I Khushalani and Jason Luke, moderated by Dr Neil Love. Produced by Research To Practice.
-
Investigator Perspectives on Available Research and Challenging Questions in Renal Cell Carcinoma: A Post-ASCO Annual Review
July 17th, 2024 | Season 1 | 1 hr 2 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the optimal management of renal cell carcinoma with Dr Rana R McKay and Prof Thomas Powles, moderated by Dr Neil Love. Produced by Research To Practice.
-
RTP Live from Chicago: Investigator Perspectives on Recent Advances and Challenging Questions in the Management of Colorectal Cancer
July 12th, 2024 | Season 1 | 1 hr 2 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the optimal management of colorectal cancer with Dr Scott Kopetz and Dr John Strickler, moderated by Dr Neil Love. Produced by Research To Practice.
-
RTP Live from Chicago: Investigator Perspectives on the Role of Bispecific Antibodies in the Management of Lymphoma
July 12th, 2024 | Season 1 | 1 hr 49 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the optimal management of lymphoma with Dr Joshua Brody, Dr Ian W Flinn and Dr Tycel Phillips, moderated by Dr Neil Love. Produced by Research To Practice.
-
What Clinicians Want to Know About the Management of Triple-Negative Breast Cancer
July 10th, 2024 | Season 1 | 1 hr 3 mins
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the selection and sequencing of optimal therapies for TNBC with Dr Kevin Kalinsky and Dr Heather McArthur, moderated by Dr Neil Love. Produced by Research To Practice.
-
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Myelofibrosis
July 1st, 2024 | Season 1 | 1 hr 6 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the optimal management of myelofibrosis with Dr Aaron T Gerds, moderated by Dr Neil Love. Produced by Research To Practice.